Free Trial

Artiva Biotherapeutics (ARTV) Insider Trading & Ownership

Artiva Biotherapeutics logo
$10.50 -0.13 (-1.22%)
Closing price 05/13/2026 04:00 PM Eastern
Extended Trading
$11.20 +0.70 (+6.62%)
As of 04:24 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Artiva Biotherapeutics (NASDAQ:ARTV) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
21.40%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$75.00M
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$263.28K
Get ARTV Insider Trade Alerts

Want to know when executives and insiders are buying or selling Artiva Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ARTV Insider Buying and Selling by Quarter

Artiva Biotherapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/11/2026
Ra Capital Management, L.P.
Director
Buy6,510,416$11.52$74,999,992.32  
12/15/2025Sell3,187$6.00$19,122.00  
11/17/2025Sell6,375$3.38$21,547.50  
10/17/2025Sell25,500$6.00$153,000.00  
8/15/2025Sell25,500$2.73$69,615.00  
(Data available from 1/1/2013 forward)

ARTV Insider Trading Activity - Frequently Asked Questions

The list of insiders at Artiva Biotherapeutics includes Fred Aslan, Global Strategic Fund I Venbio, Ra Capital Management, L.P., and Yong-Jun Huh. Learn more on insiders at ARTV.

21.40% of Artiva Biotherapeutics stock is owned by insiders. Learn more on ARTV's insider holdings.

The following insiders have purchased ARTV shares in the last 24 months: Global Strategic Fund I Venbio ($4,999,992.00), Ra Capital Management, L.P. ($74,999,992.32), and Yong-Jun Huh ($24,999,984.00).

Insiders have purchased a total of 9,010,414 ARTV shares in the last 24 months for a total of $104,999,968.32 bought.

The following insider sold ARTV shares in the last 24 months: Fred Aslan ($263,284.50).

Insiders have sold a total of 60,562 Artiva Biotherapeutics shares in the last 24 months for a total of $263,284.50 sold.



This page (NASDAQ:ARTV) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners